Analyze Diet
Veterinary anaesthesia and analgesia2018; 46(3); 395-404; doi: 10.1016/j.vaa.2018.11.001

The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses.

Abstract: Describe the pharmacokinetics and pharmacodynamics of intravenous hydromorphone in healthy horses. Methods: Masked, randomized, cross-over, Latin square design. Methods: A group of eight healthy adult horses METHODS: Horses were administered each of four treatments with an 8 day washout. Treatments groups included intravenous hydromorphone 0.02 mg kg (LD), 0.04 mg kg (MD), 0.08 mg kg (HD) and saline (P). Blood samples for hydromorphone analysis were obtained for 24 hours after treatment. Plasma hydromorphone was quantified and pharmacokinetic parameters were determined using non-compartmental analysis. Pharmacodynamic data collected for 24 hours after treatment included thermal nociceptive threshold, heart rate (HR), respiratory rate (f) and rectal temperature, and analyzed using mixed-effects linear models. Results: Mean (± standard deviation) hydromorphone terminal half-life (t), systemic clearance and apparent volume of distribution at steady state (Vd) were 18.1 ± 18.6, 34.0 ± 12.8, and 41.3 ± 32.5 minutes, 66.6 ± 5.3, 550.0 ± 76.4, and 92.7 ± 13.9 mL kg minute, and 1118 ± 369, 1460 ± 325 and 2242 ± 950 mL kg for treatments LD, MD and HD, respectively. Thermal threshold increased significantly compared to baseline for all treatments for up to 12 hours. HR was elevated above baseline in treatments LD, MD and HD, extending to 30, 15 and 105 minutes after treatment, respectively. Respiratory rate was elevated above baseline in treatments MD and HD from 30 to 195 minutes and from 45 to 480 minutes after treatment, respectively. Temperature was elevated above baseline in treatment HD until 255 minutes after treatment. Conclusions: Hydromorphone exhibited a short t, rapid clearance and large Vd in horses. It also provided a dose-dependent increase in thermal threshold with associated increases in HR, f and rectal temperature. Conclusions: Hydromorphone 0.04 mg kg provided clinically relevant thermal antinociception with minimal adverse effects.
Publication Date: 2018-11-22 PubMed ID: 30930095DOI: 10.1016/j.vaa.2018.11.001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Veterinary
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article studies how intravenous hydromorphone works in horses, its effects on certain physical parameters, and the resulted changes over time. The most effective dose was identified with minimal negative imprints.

Methodology

  • This study was carried out with a masked, randomized layout following a so-called ‘Latin square design’. The experiment was carried out on a group of eight healthy adult horses.
  • Four treatment groups were created with varying intravenous hydromorphone doses: 0.02 mg/kg (LD), 0.04 mg/kg (MD), 0.08 mg/kg (HD), and one with saline (P).
  • An 8-day washout period was provided between each treatment.
  • For a duration of a day following every treatment, blood samples were collected at regular intervals. The amount of hydromorphone in the plasma was quantified and other pharmacokinetic parameters were estimated using noncompartmental analysis.
  • In the same time frame, certain pharmacodynamic information was collected such as the thermal nociceptive threshold (essentially pain threshold), heart rate, respiratory rate, and rectal temperature. The collected data was analyzed with mixed-effects linear models.

Findings

  • The half-life, systemic clearance, and apparent volume of distribution at steady state (Vd) of hydromorphone was calculated for each of the treatment groups.
  • All the hydromorphone treatments had a significant increase in the thermal threshold compared to the baseline for up to 12 hours, indicating that the drug effectively increases the pain threshold in horses.
  • HR, respiratory rate, and rectal temperature were found to have increased above the baseline in the LD, MD, and HD treatments. The duration for which these rates stayed high varied between the groups.
  • The 0.04 mg/kg dosage offered clinically relevant thermal antinociception with minimal side effects.

Conclusion

  • The study concluded that hydromorphone has a short lifespan and is rapidly cleared from a horse’s body, yet its presence reflects in a large Vd.
  • It was also determined that the drug increases thermal threshold, heart rate, respiratory rate, and the rectal temperature of horses in a dose-dependent manner.
  • The most effective dosage was found to be 0.04 mg/kg as it provided substantial increase in thermal threshold (pain tolerance) with minimal side effects.

Cite This Article

APA
Reed R, Barletta M, Mitchell K, Hanafi A, Bullington A, Knych H, Quandt J, Ryan C, Giguère S. (2018). The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses. Vet Anaesth Analg, 46(3), 395-404. https://doi.org/10.1016/j.vaa.2018.11.001

Publication

ISSN: 1467-2995
NlmUniqueID: 100956422
Country: United States
Language: English
Volume: 46
Issue: 3
Pages: 395-404
PII: S1467-2987(18)30294-0

Researcher Affiliations

Reed, Rachel
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA. Electronic address: rreed@uga.edu.
Barletta, Michele
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Mitchell, Krista
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Hanafi, Amanda
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Bullington, Annie
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Knych, Heather
  • Department of Molecular Biosciences, University of California Davis School of Veterinary Medicine, Davis, CA, USA.
Quandt, Jane
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Ryan, Clare
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
Giguère, Steeve
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA, USA.

MeSH Terms

  • Administration, Intravenous
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Animals
  • Cross-Over Studies
  • Female
  • Horses / metabolism
  • Hydromorphone / administration & dosage
  • Hydromorphone / pharmacokinetics
  • Male
  • Random Allocation
  • Single-Blind Method
  • Temperature

Citations

This article has been cited 1 times.
  1. Hamamoto-Hardman BD, Steffey EP, McKemie DS, Kass PH, Knych HK. Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses.. BMC Vet Res 2020 Oct 1;16(1):368.
    doi: 10.1186/s12917-020-02564-4pubmed: 32998730google scholar: lookup